Literature DB >> 26215493

Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.

Dong Wook Kim1.   

Abstract

The aim of this study was to evaluate the ultrasonographic features of the major salivary glands (MSGs) after post-operative radioactive iodine ablation (RIA) in patients with papillary thyroid carcinoma (PTC). The study population comprised 202 consecutively registered PTC patients who had undergone total thyroidectomy, RIA and follow-up neck ultrasonography. The ultrasonographic features of the MSGs in each patient were retrospectively evaluated by a single radiologist, and the presence of post-RIA changes was determined by direct comparisons of pre- and post-RIA follow-up ultrasonographic scans. Of the 202 patients, 94 (46.5%) had post-RIA changes in the MSGs on follow-up ultrasonography. RIA dose was closely associated with the prevalence of post-RIA changes. Post-RIA changes were more common in the parotid glands (n = 93, 46.0%) than in the submandibular glands (n = 7, 3.5%). Common ultrasonographic findings representing post-RIA changes in MSGs included coarse echotexture, decreased echogenicity, lobulated margin and decreased gland size.
Copyright © 2015 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Major salivary glands; Papillary thyroid carcinoma; Radioactive iodine ablation; Ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 26215493     DOI: 10.1016/j.ultrasmedbio.2015.06.010

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

1.  Computed tomography features of the major salivary glands after radioactive iodine ablation in patients with papillary thyroid carcinoma.

Authors:  Dong Wook Kim
Journal:  Radiol Med       Date:  2017-09-20       Impact factor: 3.469

Review 2.  Ultrasonography of the thyroid, parathyroids, and beyond.

Authors:  Marika D Russell; Lisa A Orloff
Journal:  HNO       Date:  2022-04-01       Impact factor: 1.330

3.  Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching.

Authors:  Ye Liu; Yuhua Wang; Wanchun Zhang
Journal:  Front Surg       Date:  2022-09-22

4.  Can the ultrasound echogenicity of normal parotid and submandibular glands be used as a reference standard for normal thyroid echogenicity?

Authors:  Insik Choi; Dong Gyu Na
Journal:  Ultrasonography       Date:  2022-03-28

5.  Comparison of Prevalence and Ultrasonography Features of Thyroglossal Duct Cyst in Adults According to Radioactive Iodine Ablation.

Authors:  Yoo Jin Lee; Dong Wook Kim; Gi Won Shin; Jin Young Park; Hye Jung Choo; Ha Kyoung Park; Tae Kwun Ha; Do Hun Kim; Soo Jin Jung; Ji Sun Park; Sung Ho Moon; Ki Jung Ahn; Hye Jin Baek
Journal:  Med Sci Monit       Date:  2019-12-14

6.  Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis.

Authors:  Graziele Aparecida Simões Lima; Rossana Verónica Mendoza López; Gislaine Aparecida Ozório; Ricardo Miguel Costa de Freitas; Jose Willegaignon; Marcelo Tatit Sapienza; Maria Christina Chammas; George Barberio Coura-Filho
Journal:  Clinics (Sao Paulo)       Date:  2020-10-19       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.